Skip to main content
Top
Published in: BMC Neurology 1/2014

Open Access 01-12-2014 | Research article

Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis

Authors: Robert J Simpson, Gary McLean, Bruce Guthrie, Frances Mair, Stewart W Mercer

Published in: BMC Neurology | Issue 1/2014

Login to get access

Abstract

Background

Comorbidity in Multiple Sclerosis (MS) is associated with worse health and higher mortality. This study aims to describe clinician recorded comorbidities in people with MS.

Methods

39 comorbidities in 3826 people with MS aged ≥25 years were compared against 1,268,859 controls. Results were analysed by age, gender, and socioeconomic status, with unadjusted and adjusted Odds Ratios (ORs) calculated using logistic regression.

Results

People with MS were more likely to have one (OR 2.44; 95% CI 2.26-2.64), two (OR 1.49; 95% CI 1.38-1.62), three (OR 1.86; 95% CI 1.69-2.04), four or more (OR 1.61; 95% CI 1.47-1.77) non-MS chronic conditions than controls, and greater mental health comorbidity (OR 2.94; 95% CI 2.75-3.14), which increased as the number of physical comorbidities rose. Cardiovascular conditions, including atrial fibrillation (OR 0.49; 95% CI 0.36-0.67), chronic kidney disease (OR 0.51; 95% CI 0.40-0.65), heart failure (OR 0.62; 95% CI 0.45-0.85), coronary heart disease (OR 0.64; 95% CI 0.52-0.71), and hypertension (OR 0.65; 95% CI 0.59-0.72) were significantly less common in people with MS.

Conclusion

People with MS have excess multiple chronic conditions, with associated increased mental health comorbidity. The low recorded cardiovascular comorbidity warrants further investigation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chwastiak LA, Ehde DM: Psychiatric issues in multiple sclerosis. Psychiatr Clin N Am. 2007, 30 (4): 803-817. 10.1016/j.psc.2007.07.003.CrossRef Chwastiak LA, Ehde DM: Psychiatric issues in multiple sclerosis. Psychiatr Clin N Am. 2007, 30 (4): 803-817. 10.1016/j.psc.2007.07.003.CrossRef
2.
go back to reference Kobelt G, Berg J, Lindgren P, Fredrikson S, Jönsson B: Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2006, 77 (8): 918-926. 10.1136/jnnp.2006.090365.CrossRefPubMedPubMedCentral Kobelt G, Berg J, Lindgren P, Fredrikson S, Jönsson B: Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2006, 77 (8): 918-926. 10.1136/jnnp.2006.090365.CrossRefPubMedPubMedCentral
3.
go back to reference Koutsouraki E, Costa V, Baloyannis S: Epidemiology of multiple sclerosis in Europe: a review. Int Rev Psychiatry. 2010, 22 (1): 2-13. 10.3109/09540261003589216.CrossRefPubMed Koutsouraki E, Costa V, Baloyannis S: Epidemiology of multiple sclerosis in Europe: a review. Int Rev Psychiatry. 2010, 22 (1): 2-13. 10.3109/09540261003589216.CrossRefPubMed
4.
go back to reference Handel AE, Jarvis L, McLaughlin R, Fries A, Ebers GC, Ramagopalan SV: The epidemiology of multiple sclerosis in Scotland: inferences from hospital admissions. PLoS One. 2011, 6 (1): e14606-10.1371/journal.pone.0014606.CrossRefPubMedPubMedCentral Handel AE, Jarvis L, McLaughlin R, Fries A, Ebers GC, Ramagopalan SV: The epidemiology of multiple sclerosis in Scotland: inferences from hospital admissions. PLoS One. 2011, 6 (1): e14606-10.1371/journal.pone.0014606.CrossRefPubMedPubMedCentral
5.
go back to reference D’hooghe M, Haentjens P, Nagels G, De Keyser J: Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis. Eur J Neurol. 2012, 19 (4): 616-624. 10.1111/j.1468-1331.2011.03596.x.CrossRefPubMed D’hooghe M, Haentjens P, Nagels G, De Keyser J: Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis. Eur J Neurol. 2012, 19 (4): 616-624. 10.1111/j.1468-1331.2011.03596.x.CrossRefPubMed
6.
go back to reference Hall SF: A user’s guide to selecting a comorbidity index for clinical research. J Clin Epidemiol. 2006, 59 (8): 849-855. 10.1016/j.jclinepi.2005.11.013.CrossRefPubMed Hall SF: A user’s guide to selecting a comorbidity index for clinical research. J Clin Epidemiol. 2006, 59 (8): 849-855. 10.1016/j.jclinepi.2005.11.013.CrossRefPubMed
7.
go back to reference Marrie R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T: The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated. Mult Scler. 2009, 15 (3): 385-392. 10.1177/1352458508099477.CrossRefPubMed Marrie R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T: The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated. Mult Scler. 2009, 15 (3): 385-392. 10.1177/1352458508099477.CrossRefPubMed
8.
go back to reference Berkovich R, Subhani D, Steinman L: Autoimmune Comorbid Conditions in Multiple Sclerosis. US Neurol. 2011, 7 (2): 132-138.CrossRef Berkovich R, Subhani D, Steinman L: Autoimmune Comorbid Conditions in Multiple Sclerosis. US Neurol. 2011, 7 (2): 132-138.CrossRef
9.
go back to reference Marrie R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T: Comorbidity, socioeconomic status and multiple sclerosis. Mult Scler. 2008, 14 (8): 1091-1098. 10.1177/1352458508092263.CrossRefPubMed Marrie R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T: Comorbidity, socioeconomic status and multiple sclerosis. Mult Scler. 2008, 14 (8): 1091-1098. 10.1177/1352458508092263.CrossRefPubMed
10.
go back to reference Warren S, Turpin K, Pohar S, Jones C, Warren K: Comorbidity and health-related quality of life in people with multiple sclerosis. Int J of MS Care. 2009, 11 (1): 6-16. 10.7224/1537-2073-11.1.6.CrossRef Warren S, Turpin K, Pohar S, Jones C, Warren K: Comorbidity and health-related quality of life in people with multiple sclerosis. Int J of MS Care. 2009, 11 (1): 6-16. 10.7224/1537-2073-11.1.6.CrossRef
11.
go back to reference Kang JH, Chen YH, Lin HC: Comorbidities amongst patients with multiple sclerosis: a population‒based controlled study. Eur J Neurol. 2010, 17 (9): 1215-1219. 10.1111/j.1468-1331.2010.02971.x.CrossRefPubMed Kang JH, Chen YH, Lin HC: Comorbidities amongst patients with multiple sclerosis: a population‒based controlled study. Eur J Neurol. 2010, 17 (9): 1215-1219. 10.1111/j.1468-1331.2010.02971.x.CrossRefPubMed
12.
go back to reference Salter AR, Tyry T, Vollmer T, Cutter GR, Marrie RA: “Seeing” in NARCOMS: a look at vision-related quality of life in the NARCOMS registry. Mult Scler. 2013, 19 (7): 953-960. 10.1177/1352458512469694.CrossRefPubMed Salter AR, Tyry T, Vollmer T, Cutter GR, Marrie RA: “Seeing” in NARCOMS: a look at vision-related quality of life in the NARCOMS registry. Mult Scler. 2013, 19 (7): 953-960. 10.1177/1352458512469694.CrossRefPubMed
13.
go back to reference Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B: Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012, 380 (9836): 37-43. 10.1016/S0140-6736(12)60240-2.CrossRefPubMed Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B: Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012, 380 (9836): 37-43. 10.1016/S0140-6736(12)60240-2.CrossRefPubMed
15.
go back to reference Carstairs V, Morris R: Deprivation and health in Scotland. Health Bull. 1990, 4 (48): 162-175. Carstairs V, Morris R: Deprivation and health in Scotland. Health Bull. 1990, 4 (48): 162-175.
16.
go back to reference Dallmeijer A, Beckerman H, de Groot V, van de Port I, Lankhorst G, Dekker J: Long-term effect of comorbidity on the course of physical functioning in patients after stroke and with multiple sclerosis. J Rehabil Med. 2009, 41 (5): 322-326. 10.2340/16501977-0335.CrossRefPubMed Dallmeijer A, Beckerman H, de Groot V, van de Port I, Lankhorst G, Dekker J: Long-term effect of comorbidity on the course of physical functioning in patients after stroke and with multiple sclerosis. J Rehabil Med. 2009, 41 (5): 322-326. 10.2340/16501977-0335.CrossRefPubMed
17.
go back to reference Foley JF, Brandes DW: Redefining functionality and treatment efficacy in multiple sclerosis. Neurology. 2009, 72 (23 Supplement 5): S1-S11.CrossRefPubMed Foley JF, Brandes DW: Redefining functionality and treatment efficacy in multiple sclerosis. Neurology. 2009, 72 (23 Supplement 5): S1-S11.CrossRefPubMed
18.
go back to reference Marrie RA, Horwitz R, Cutter G, Tyry T: Cumulative impact of comorbidity on quality of life in MS. Acta Neurol Scand. 2012, 125 (3): 180-186. 10.1111/j.1600-0404.2011.01526.x.CrossRefPubMed Marrie RA, Horwitz R, Cutter G, Tyry T: Cumulative impact of comorbidity on quality of life in MS. Acta Neurol Scand. 2012, 125 (3): 180-186. 10.1111/j.1600-0404.2011.01526.x.CrossRefPubMed
19.
go back to reference Lawson KD, Mercer SW, Wyke S, Grieve E, Guthrie B, Watt GC, Fenwick EA: Double trouble: the impact of multimorbidity and deprivation on preference-weighted health related quality of life a cross sectional analysis of the Scottish Health Survey. Int J Equity Health. 2013, 12 (1): 67-10.1186/1475-9276-12-67.CrossRefPubMedPubMedCentral Lawson KD, Mercer SW, Wyke S, Grieve E, Guthrie B, Watt GC, Fenwick EA: Double trouble: the impact of multimorbidity and deprivation on preference-weighted health related quality of life a cross sectional analysis of the Scottish Health Survey. Int J Equity Health. 2013, 12 (1): 67-10.1186/1475-9276-12-67.CrossRefPubMedPubMedCentral
20.
go back to reference Marrie R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T: Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology. 2009, 72 (2): 117-124. 10.1212/01.wnl.0000333252.78173.5f.CrossRefPubMedPubMedCentral Marrie R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T: Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology. 2009, 72 (2): 117-124. 10.1212/01.wnl.0000333252.78173.5f.CrossRefPubMedPubMedCentral
21.
go back to reference Paparrigopoulos T, Ferentinos P, Kouzoupis A, Koutsis G, Papadimitriou GN: The neuropsychiatry of multiple sclerosis: focus on disorders of mood, affect and behaviour. Int Rev Psychiatry. 2010, 22 (1): 14-21. 10.3109/09540261003589323.CrossRefPubMed Paparrigopoulos T, Ferentinos P, Kouzoupis A, Koutsis G, Papadimitriou GN: The neuropsychiatry of multiple sclerosis: focus on disorders of mood, affect and behaviour. Int Rev Psychiatry. 2010, 22 (1): 14-21. 10.3109/09540261003589323.CrossRefPubMed
22.
go back to reference McGuigan C, Hutchinson M: Unrecognised symptoms of depression in a community–based population with multiple sclerosis. J Neurol. 2006, 253 (2): 219-223. 10.1007/s00415-005-0963-0.CrossRefPubMed McGuigan C, Hutchinson M: Unrecognised symptoms of depression in a community–based population with multiple sclerosis. J Neurol. 2006, 253 (2): 219-223. 10.1007/s00415-005-0963-0.CrossRefPubMed
23.
go back to reference Marrie RA, Cutter G, Tyry T, Campagnolo D, Vollmer T: Effect of physical comorbidities on risk of depression in multiple sclerosis. Int J MS Care. 2009, 11 (4): 161-165. 10.7224/1537-2073-11.4.161.CrossRef Marrie RA, Cutter G, Tyry T, Campagnolo D, Vollmer T: Effect of physical comorbidities on risk of depression in multiple sclerosis. Int J MS Care. 2009, 11 (4): 161-165. 10.7224/1537-2073-11.4.161.CrossRef
24.
go back to reference Najjar S, Pearlman DM, Devinsky O, Najjar A, Zagzag D: Neurovascular unit dysfunction with blood–brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. J Neuroinflammation. 2013, 10 (1): 142-10.1186/1742-2094-10-142.CrossRefPubMedPubMedCentral Najjar S, Pearlman DM, Devinsky O, Najjar A, Zagzag D: Neurovascular unit dysfunction with blood–brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. J Neuroinflammation. 2013, 10 (1): 142-10.1186/1742-2094-10-142.CrossRefPubMedPubMedCentral
25.
go back to reference Carta M, Moro M, Lorefice L, Trincas G, Cocco E, Giudice ED, Fenu G, Colom F, Marrosu MG: The risk of Bipolar disorders in Multiple Sclerosis. J Affect Disord. 2014, 155: 255-260.CrossRefPubMed Carta M, Moro M, Lorefice L, Trincas G, Cocco E, Giudice ED, Fenu G, Colom F, Marrosu MG: The risk of Bipolar disorders in Multiple Sclerosis. J Affect Disord. 2014, 155: 255-260.CrossRefPubMed
26.
go back to reference Smith D, Griffiths E, Kelly M, Hood K, Craddock N, Simpson S: Unrecognised bipolar disorder in primary care patients with depression. Br J Psychiatry. 2011, 199 (1): 49-56. 10.1192/bjp.bp.110.083840.CrossRefPubMed Smith D, Griffiths E, Kelly M, Hood K, Craddock N, Simpson S: Unrecognised bipolar disorder in primary care patients with depression. Br J Psychiatry. 2011, 199 (1): 49-56. 10.1192/bjp.bp.110.083840.CrossRefPubMed
27.
go back to reference Merikangas K, Jin R, He JP, Kessler R, Lee S, Sampson N, Viana MC, Andrade LH, Hu C, Karam E, Ladea M, Mora MEM, Browne MO, Ono Y, Posada-Villa J, Sagar R, Zarkov Z: Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011, 68 (3): 241-251. 10.1001/archgenpsychiatry.2011.12.CrossRefPubMedPubMedCentral Merikangas K, Jin R, He JP, Kessler R, Lee S, Sampson N, Viana MC, Andrade LH, Hu C, Karam E, Ladea M, Mora MEM, Browne MO, Ono Y, Posada-Villa J, Sagar R, Zarkov Z: Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011, 68 (3): 241-251. 10.1001/archgenpsychiatry.2011.12.CrossRefPubMedPubMedCentral
28.
go back to reference Mohr D, Hart S, Fonareva I, Tasch E: Treatment of depression for patients with multiple sclerosis in neurology clinics. Mult Scler. 2006, 12 (2): 204-208. 10.1191/135248506ms1265oa.CrossRefPubMed Mohr D, Hart S, Fonareva I, Tasch E: Treatment of depression for patients with multiple sclerosis in neurology clinics. Mult Scler. 2006, 12 (2): 204-208. 10.1191/135248506ms1265oa.CrossRefPubMed
29.
go back to reference Maxwell M, Harris F, Hibberd C, Donaghy E, Pratt R, Williams C, Morrison J, Gibb J, Watson P, Burton C: A qualitative study of primary care professionals’ views of case finding for depression in patients with diabetes or coronary heart disease in the UK. BMC Fam Pract. 2013, 14 (1): 46-10.1186/1471-2296-14-46.CrossRefPubMedPubMedCentral Maxwell M, Harris F, Hibberd C, Donaghy E, Pratt R, Williams C, Morrison J, Gibb J, Watson P, Burton C: A qualitative study of primary care professionals’ views of case finding for depression in patients with diabetes or coronary heart disease in the UK. BMC Fam Pract. 2013, 14 (1): 46-10.1186/1471-2296-14-46.CrossRefPubMedPubMedCentral
30.
go back to reference Koch M, Uyttenboogaart M, Polman S, De Keyser J: Seizures in multiple sclerosis. Epilepsia. 2008, 49 (6): 948-953. 10.1111/j.1528-1167.2008.01565.x.CrossRefPubMed Koch M, Uyttenboogaart M, Polman S, De Keyser J: Seizures in multiple sclerosis. Epilepsia. 2008, 49 (6): 948-953. 10.1111/j.1528-1167.2008.01565.x.CrossRefPubMed
31.
go back to reference Kratz A, Molton I, Jensen M, Ehde D, Nielson W: Further evaluation of the motivational model of pain self-management: coping with Chronic pain in Multiple Sclerosis. Ann Behav Med. 2011, 41 (3): 391-400. 10.1007/s12160-010-9249-6.CrossRefPubMedPubMedCentral Kratz A, Molton I, Jensen M, Ehde D, Nielson W: Further evaluation of the motivational model of pain self-management: coping with Chronic pain in Multiple Sclerosis. Ann Behav Med. 2011, 41 (3): 391-400. 10.1007/s12160-010-9249-6.CrossRefPubMedPubMedCentral
32.
go back to reference Doi H, Matsushita T, Isobe N, Ishizu T, Ohyagi Y, Kira J-i: Frequency of chronic headaches in Japanese patients with Multiple Sclerosis: with special reference to Opticospinal and common forms of Multiple Sclerosis. Headache: J of Head Face Pain. 2009, 49 (10): 1513-1520. 10.1111/j.1526-4610.2009.01427.x.CrossRef Doi H, Matsushita T, Isobe N, Ishizu T, Ohyagi Y, Kira J-i: Frequency of chronic headaches in Japanese patients with Multiple Sclerosis: with special reference to Opticospinal and common forms of Multiple Sclerosis. Headache: J of Head Face Pain. 2009, 49 (10): 1513-1520. 10.1111/j.1526-4610.2009.01427.x.CrossRef
33.
go back to reference Pakpoor J, Handel AE, Giovannoni G, Dobson R, Ramagopalan SV: Meta-Analysis of the relationship between Multiple Sclerosis and Migraine. PLoS One. 2012, 7 (9): e45295-10.1371/journal.pone.0045295.CrossRefPubMedPubMedCentral Pakpoor J, Handel AE, Giovannoni G, Dobson R, Ramagopalan SV: Meta-Analysis of the relationship between Multiple Sclerosis and Migraine. PLoS One. 2012, 7 (9): e45295-10.1371/journal.pone.0045295.CrossRefPubMedPubMedCentral
34.
go back to reference Preziosi G, Raptis DA, Raeburn A, Thiruppathy K, Panicker J, Emmanuel A: Gut dysfunction in patients with multiple sclerosis and the role of spinal cord involvement in the disease. Eur J Gastroenterol Hepatol. 2013, 25 (9): 1044-1050. 10.1097/MEG.0b013e328361eaf8.CrossRefPubMedPubMedCentral Preziosi G, Raptis DA, Raeburn A, Thiruppathy K, Panicker J, Emmanuel A: Gut dysfunction in patients with multiple sclerosis and the role of spinal cord involvement in the disease. Eur J Gastroenterol Hepatol. 2013, 25 (9): 1044-1050. 10.1097/MEG.0b013e328361eaf8.CrossRefPubMedPubMedCentral
35.
go back to reference Marrie R, Rudick R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T: Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology. 2010, 74 (13): 1041-1047. 10.1212/WNL.0b013e3181d6b125.CrossRefPubMedPubMedCentral Marrie R, Rudick R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T: Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology. 2010, 74 (13): 1041-1047. 10.1212/WNL.0b013e3181d6b125.CrossRefPubMedPubMedCentral
36.
go back to reference Wens I, Dalgas U, Stenager E, Eijnde BO: Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis–a systematic review. Mult Scler. 2013, 19 (12): 1556-1564. 10.1177/1352458513504252.CrossRefPubMed Wens I, Dalgas U, Stenager E, Eijnde BO: Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis–a systematic review. Mult Scler. 2013, 19 (12): 1556-1564. 10.1177/1352458513504252.CrossRefPubMed
37.
go back to reference Smith DJ, Martin D, McLean G, Langan J, Guthrie B, Mercer SW: Multimorbidity in bipolar disorder and undertreatment of cardiovascular disease: a cross sectional study. BMC Med. 2013, 11 (1): 263-10.1186/1741-7015-11-263.CrossRefPubMedPubMedCentral Smith DJ, Martin D, McLean G, Langan J, Guthrie B, Mercer SW: Multimorbidity in bipolar disorder and undertreatment of cardiovascular disease: a cross sectional study. BMC Med. 2013, 11 (1): 263-10.1186/1741-7015-11-263.CrossRefPubMedPubMedCentral
38.
go back to reference Mackenzie IS, Morant SV, Bloomfield GA, MacDonald TM, O’Riordan JO: Incidence and prevalence of multiple sclerosis in the UK 1990–2010: a descriptive study in the General Practice Research Database. J Neurol Neurosurg Psychiatry. 2014, 85 (1): 76-84. 10.1136/jnnp-2013-305450.CrossRefPubMed Mackenzie IS, Morant SV, Bloomfield GA, MacDonald TM, O’Riordan JO: Incidence and prevalence of multiple sclerosis in the UK 1990–2010: a descriptive study in the General Practice Research Database. J Neurol Neurosurg Psychiatry. 2014, 85 (1): 76-84. 10.1136/jnnp-2013-305450.CrossRefPubMed
40.
go back to reference Khan NF, Harrison SE, Rose PW: Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract. 2010, 60 (572): e128-e136. 10.3399/bjgp10X483562.CrossRefPubMedPubMedCentral Khan NF, Harrison SE, Rose PW: Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract. 2010, 60 (572): e128-e136. 10.3399/bjgp10X483562.CrossRefPubMedPubMedCentral
41.
go back to reference Von Korff M, Katon WJ, Lin EH, Ciechanowski P, Peterson D, Ludman EJ, Young B, Rutter CM: Functional outcomes of multi-condition collaborative care and successful ageing: results of randomised trial. Br Med J. 2011, 10: 343- Von Korff M, Katon WJ, Lin EH, Ciechanowski P, Peterson D, Ludman EJ, Young B, Rutter CM: Functional outcomes of multi-condition collaborative care and successful ageing: results of randomised trial. Br Med J. 2011, 10: 343-
42.
go back to reference Katon WJ, Lin EH, Von Korff M, Ciechanowski P, Ludman EJ, Young B, Peterson D, Rutter CM, McGregor M, McCulloch D: Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010, 363 (27): 2611-2620. 10.1056/NEJMoa1003955.CrossRefPubMedPubMedCentral Katon WJ, Lin EH, Von Korff M, Ciechanowski P, Ludman EJ, Young B, Peterson D, Rutter CM, McGregor M, McCulloch D: Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010, 363 (27): 2611-2620. 10.1056/NEJMoa1003955.CrossRefPubMedPubMedCentral
Metadata
Title
Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis
Authors
Robert J Simpson
Gary McLean
Bruce Guthrie
Frances Mair
Stewart W Mercer
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2014
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/1471-2377-14-128

Other articles of this Issue 1/2014

BMC Neurology 1/2014 Go to the issue